These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 22734710)
1. Integrated ligand based pharmacophore model derived from diverse FAAH covalent ligand classes. Shen L; Huang H; Makriyannis A; Fisher LS Curr Comput Aided Drug Des; 2012 Dec; 8(4):330-4. PubMed ID: 22734710 [TBL] [Abstract][Full Text] [Related]
2. Approximating protein flexibility through dynamic pharmacophore models: application to fatty acid amide hydrolase (FAAH). Bowman AL; Makriyannis A J Chem Inf Model; 2011 Dec; 51(12):3247-53. PubMed ID: 22098169 [TBL] [Abstract][Full Text] [Related]
3. Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure. Lodola A; Rivara S; Mor M Adv Protein Chem Struct Biol; 2011; 85():1-26. PubMed ID: 21920320 [TBL] [Abstract][Full Text] [Related]
4. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs. Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963 [TBL] [Abstract][Full Text] [Related]
5. Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology. Lamani M; Malamas MS; Farah SI; Shukla VG; Almeida MF; Weerts CM; Anderson J; Wood JT; Farizatto KLG; Bahr BA; Makriyannis A Bioorg Med Chem; 2019 Dec; 27(23):115096. PubMed ID: 31629610 [TBL] [Abstract][Full Text] [Related]
6. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation. Halder AK; Saha A; Saha KD; Jha T J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685 [TBL] [Abstract][Full Text] [Related]
7. Insights from ligand and structure based methods in virtual screening of selective Ni-peptide deformylase inhibitors. Ananthula RS; Ravikumar M; Mahmood SK; Kumar MN J Mol Model; 2012 Feb; 18(2):693-708. PubMed ID: 21562829 [TBL] [Abstract][Full Text] [Related]
8. Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8. Kalva S; Vinod D; Saleena LM J Mol Model; 2014 May; 20(5):2191. PubMed ID: 24756550 [TBL] [Abstract][Full Text] [Related]
9. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches. Jana S; Singh SK J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408 [TBL] [Abstract][Full Text] [Related]
10. Arylboronic acids as dual-action FAAH and TRPV1 ligands. Morera E; Di Marzo V; Monti L; Allarà M; Schiano Moriello A; Nalli M; Ortar G; De Petrocellis L Bioorg Med Chem Lett; 2016 Mar; 26(5):1401-5. PubMed ID: 26850005 [TBL] [Abstract][Full Text] [Related]
11. 3D Pharmacophore-Based Virtual Screening and Docking Approaches toward the Discovery of Novel HPPD Inhibitors. Fu Y; Sun YN; Yi KH; Li MQ; Cao HF; Li JZ; Ye F Molecules; 2017 Jun; 22(6):. PubMed ID: 28598377 [No Abstract] [Full Text] [Related]
12. Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products. Gao Q; Wang Y; Hou J; Yao Q; Zhang J J Comput Aided Mol Des; 2017 Jul; 31(7):625-641. PubMed ID: 28623487 [TBL] [Abstract][Full Text] [Related]
13. Identification of new dual spleen tyrosine kinase (Syk) and phosphoionositide-3-kinase δ (PI3Kδ) inhibitors using ligand and structure-based integrated ideal pharmacophore models. Kaur M; Silakari O SAR QSAR Environ Res; 2016 Jun; 27(6):469-99. PubMed ID: 27431536 [TBL] [Abstract][Full Text] [Related]
15. Identification of ligand features essential for HDACs inhibitors by pharmacophore modeling. Chen YD; Jiang YJ; Zhou JW; Yu QS; You QD J Mol Graph Model; 2008 Apr; 26(7):1160-8. PubMed ID: 18061500 [TBL] [Abstract][Full Text] [Related]
16. Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling. Bjij I; Ramharack P; Khan S; Cherqaoui D; Soliman MES Molecules; 2019 Aug; 24(17):. PubMed ID: 31466292 [TBL] [Abstract][Full Text] [Related]
17. Combiphore (Structure and Ligand Based Pharmacophore) - Approach for the Design of GPR40 Modulators in the Management of Diabetes. Gajjar KA; Gajjar AK Curr Drug Discov Technol; 2020; 17(2):233-247. PubMed ID: 30306872 [TBL] [Abstract][Full Text] [Related]
18. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification. Islam MA; Pillay TS J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527 [TBL] [Abstract][Full Text] [Related]
19. Design, microwave-assisted synthesis, biological evaluation and molecular modeling studies of 4-phenylthiazoles as potent fatty acid amide hydrolase inhibitors. Wilt SR; Rodriguez M; Le TNH; Baltodano EV; Salas A; Pecic S Chem Biol Drug Des; 2020 May; 95(5):534-547. PubMed ID: 32061147 [TBL] [Abstract][Full Text] [Related]